TC Biopharm is a biopharmaceutical company that develops immunotherapy products using its gamma delta T cell platform. Its product pipeline includes OmnImmune for acute myeloid leukemia treatment and ImmuniStim for COVID-19 treatment. It was founded in 2013 and is based in Motherwell, UK.